A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the analgesic (painkiller) effectiveness and safety
of combination of tramadol HCI (37.5 mg)/acetaminophen (325 mg) in the treatment of chronic
cancer pain.